DLGAP5 and familial pancreatic carcinoma: Compared with the low expression group, patients with pancreatic cancer in the high expression group had much shorter OS and PFS, indicating that the DLGAP5 expression is related to the OS and disease-free survival of patients with pancreatic cancer.